Great West Life Assurance CO Seres Therapeutics, Inc. Transaction History

Great West Life Assurance CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$4.67 - $6.55 $72,469 - $101,642	15,518 Added 57.28%	42,609 $205,000
Q1 2023 May 12, 2023	BUY	$4.95 - $6.09 $113,246 - $139,327	22,878 Added 543.03%	27,091 $154,000
Q3 2022 Nov 01, 2022	BUY	$3.5 - $7.2 $14,745 - $30,333	4,213 New	4,213 $27,000
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $97,952 - $158,956	4,213 New	4,213 $103,000
Q2 2019 Jul 31, 2019	SELL	$2.28 - $7.35 $15,453 - $49,818	-6,778 Closed	0 $0

Q4 2018 Feb 12, 2019	BUY	$4.52 - $8.88 $30,636 - $60,188	6,778 New	6,778 $30,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.